TIDMIMM

RNS Number : 9201G

Immupharma PLC

19 May 2011

 
 For Immediate Release   19 May 2011

ImmuPharma PLC

Result of Annual General Meeting

ImmuPharma PLC (AIM:IMM), the specialist drug discovery and development company, held its AGM earlier today and is pleased to announce that all resolutions were duly passed.

- End -

For further information please contact:

ImmuPharma PLC:

Dr Robert Zimmer, President & Chief Scientific Officer + 33 389 32 76 50

Dimitri Dimitriou, Chief Executive Officer +44 20 7152 4080

Richard Warr, Chairman +44 20 7152 4080

Buchanan Communications

Lisa Baderoon

Mark Court +44 20 7466 5000

Panmure, Gordon & Co., NOMAD & Broker

Andrew Burnett

Rakesh Sharma +44 20 7459 3600

Espirito Santo Investment Bank

James Bromhead

Richard Crawley +44 20 7456 9191

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGBGGDUIBBBGBC

Immupharma (LSE:IMM)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Immupharma Charts.
Immupharma (LSE:IMM)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Immupharma Charts.